| WINNIPEG, MANITOBA--(Marketwire - April 20, 2012) - Medicure Inc. (" Medicure " or the " Company ") (TSX VENTURE:MPH)(PINKSHEETS:MCUJ), a specialty pharmaceutical company, today reported its third quarter 2012 financial results. Third Quarter 2012 Highlights: Recorded $4.4 million of revenue during the nine months ended February 29, 2012 compared to $2.9 million for the same period last year; Net revenue from the sale of AGGRASTAT ® finished product decreased compared to third qu...continued MCUJ MPH:CA Services |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment